Clinical Trial Update: A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg [Phase 2, Phase 3]

View source ↗

Summary

This document updates on an ongoing Phase 2/3 pilot clinical trial comparing full-dose rivaroxaban to a prophylactic dose for superficial vein thrombosis of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Superficial Vein Thrombosis
• Thrombosis

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: SVT, Thrombosis | Phase 2, Phase 3 | Status: RECRUITING